{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:03:49Z","timestamp":1791929029247,"version":"4.3.4"},"reference-count":66,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T00:00:00Z","timestamp":1456876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.amepre.2015.10.012","type":"journal-article","created":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T05:09:57Z","timestamp":1452488997000},"page":"S74-S80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":114,"special_numbering":"S1","title":["Retrospective Assessment of Cost Savings From Prevention"],"prefix":"10.1016","volume":"50","author":[{"given":"Scott D.","family":"Grosse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mick Tilford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Kucik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman J.","family":"Waitzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.amepre.2015.10.012_bib1","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJM199212243272602","article-title":"Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation","volume":"327","author":"Czeizel","year":"1992","journal-title":"N Engl J Med"},{"issue":"8760","key":"10.1016\/j.amepre.2015.10.012_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0140-6736(91)90133-A","article-title":"Prevention of neural tube defects: results of the Medical Research Council Vitamin Study","volume":"338","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.amepre.2015.10.012_bib3","first-page":"8781","article-title":"Food standards: amendments of standards of identity for enriched grain products to require addition of folic acid","volume":"61","year":"1996","journal-title":"Federal Register"},{"issue":"31","key":"10.1016\/j.amepre.2015.10.012_bib4","first-page":"980","article-title":"CDC Grand Rounds: additional opportunities to prevent neural tube defects with folic acid fortification","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amepre.2015.10.012_bib5","series-title":"Dissemination and Implementation Research in Health","first-page":"72","article-title":"Comparative effectiveness research to accelerate translation: Recommendations for an emerging field of science","author":"Glasgow","year":"2012"},{"issue":"5","key":"10.1016\/j.amepre.2015.10.012_bib6","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2105\/AJPH.85.5.667","article-title":"Folic acid fortification of grain: an economic analysis","volume":"85","author":"Romano","year":"1995","journal-title":"Am J Public Health"},{"key":"10.1016\/j.amepre.2015.10.012_bib7","series-title":"Cost-Effectiveness in Health and Medicine","first-page":"312","article-title":"Cost-effectiveness of strategies to prevent neural tube defects","author":"Kelly","year":"1996"},{"key":"10.1016\/j.amepre.2015.10.012_bib8","first-page":"53305","article-title":"Food standards: amendment of the standards of identity for enriched grain products to require addition of folic acid","volume":"58","year":"1993","journal-title":"Federal Register"},{"issue":"21","key":"10.1016\/j.amepre.2015.10.012_bib9","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1001\/jama.1995.03530210052030","article-title":"Folate levels and neural tube defects. Implications for prevention","volume":"274","author":"Daly","year":"1995","journal-title":"JAMA"},{"issue":"9298","key":"10.1016\/j.amepre.2015.10.012_bib10","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/S0140-6736(01)07104-5","article-title":"Quantifying the effect of folic acid","volume":"358","author":"Wald","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.amepre.2015.10.012_bib11","doi-asserted-by":"crossref","first-page":"g4554","DOI":"10.1136\/bmj.g4554","article-title":"Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model","volume":"349","author":"Crider","year":"2014","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.amepre.2015.10.012_bib12","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2105\/AJPH.2004.058859","article-title":"Reevaluating the benefits of folic acid fortification in the United States: economic analysis, regulation, and public health","volume":"95","author":"Grosse","year":"2005","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.amepre.2015.10.012_bib13","first-page":"1","article-title":"Updated estimates of neural tube defects prevented by mandatory folic acid fortification - United States, 1995-2011","volume":"64","author":"Williams","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"10.1016\/j.amepre.2015.10.012_bib14","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/bdra.20735","article-title":"Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006","volume":"88","author":"Parker","year":"2010","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"9","key":"10.1016\/j.amepre.2015.10.012_bib15","first-page":"1","article-title":"Births: final data for 2012","volume":"62","author":"Martin","year":"2013","journal-title":"Natl Vital Stat Rep"},{"issue":"6","key":"10.1016\/j.amepre.2015.10.012_bib16","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/bdra.23378","article-title":"Crider K.S.U.S. women of childbearing age who are at possible increased risk of a neural tube defect-affected pregnancy due to suboptimal red blood cell folate concentrations, National Health and Nutrition Examination Survey 2007 to 2012","volume":"103","author":"Tinker","year":"2015","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.amepre.2015.10.012_bib17","first-page":"8797","article-title":"Food additives permitted for direct addition to food for human consumption; folic acid (folacin), final rule","volume":"61","year":"1996","journal-title":"Federal Register"},{"issue":"5","key":"10.1016\/j.amepre.2015.10.012_bib18","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3945\/jn.111.156919","article-title":"Estimation of trends in serum and RBC folate in the U.S. population from pre- to postfortification using assay-adjusted data from the NHANES 1988-2010","volume":"142","author":"Pfeiffer","year":"2012","journal-title":"J Nutr"},{"issue":"3","key":"10.1016\/j.amepre.2015.10.012_bib19","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/ajcn\/86.3.718","article-title":"Trends in blood folate and vitamin B-12 concentrations in the United States, 1988-2004","volume":"86","author":"Pfeiffer","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.amepre.2015.10.012_bib20","series-title":"Cost-Effectiveness in Health and Medicine","author":"Gold","year":"1996"},{"issue":"6","key":"10.1016\/j.amepre.2015.10.012_bib21","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.amepre.2008.07.008","article-title":"Economic evaluation of a neural tube defect recurrence-prevention program","volume":"35","author":"Grosse","year":"2008","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.amepre.2015.10.012_bib22","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"1997"},{"key":"10.1016\/j.amepre.2015.10.012_bib23","series-title":"The Cost of Birth Defects","author":"Waitzman","year":"1996"},{"key":"10.1016\/j.amepre.2015.10.012_bib24","series-title":"Neural Tube Defects: From Origin to Treatment","first-page":"342","article-title":"Half-life of cost of illness estimates: The case of spina bifida","author":"Waitzman","year":"2005"},{"issue":"7","key":"10.1016\/j.amepre.2015.10.012_bib25","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/bdra.20360","article-title":"Health care expenditures of children and adults with spina bifida in a privately insured U.S. population","volume":"79","author":"Ouyang","year":"2007","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"6","key":"10.1016\/j.amepre.2015.10.012_bib26","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jpeds.2012.05.040","article-title":"Improved survival among children with spina bifida in the United States","volume":"161","author":"Shin","year":"2012","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.amepre.2015.10.012_bib27","first-page":"25","article-title":"Hospital stays, hospital charges, and in-hospital deaths among infants with selected birth defects--United States, 2003","volume":"56","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.amepre.2015.10.012_bib28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/0272989X08322014","article-title":"Labor market productivity costs for caregivers of children with spina bifida: a population-based analysis","volume":"29","author":"Tilford","year":"2009","journal-title":"Med Decis Making"},{"issue":"1","key":"10.1016\/j.amepre.2015.10.012_bib29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jpeds.2010.12.037","article-title":"Long term maintenance of neural tube defects prevention in a high prevalence state","volume":"159","author":"Collins","year":"2011","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.amepre.2015.10.012_bib30","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/ajmg.a.36324","article-title":"A description of spina bifida cases and co-occurring malformations, 1976-2011","volume":"164","author":"Parker","year":"2014","journal-title":"Am J Med Genet A"},{"issue":"9","key":"10.1016\/j.amepre.2015.10.012_bib31","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/bdra.20485","article-title":"Spina bifida before and after folic acid fortification in Canada","volume":"82","author":"De Wals","year":"2008","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"6","key":"10.1016\/j.amepre.2015.10.012_bib32","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s40273-013-0040-y","article-title":"Disutility of illness for caregivers and families: a systematic review of the literature","volume":"31","author":"Wittenberg","year":"2013","journal-title":"Pharmacoeconomics"},{"issue":"10","key":"10.1016\/j.amepre.2015.10.012_bib33","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2165\/00019053-200826100-00003","article-title":"Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions?","volume":"26","author":"Rappange","year":"2008","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"10.1016\/j.amepre.2015.10.012_bib34","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s10826-009-9260-3","article-title":"Impact of spina bifida on parental caregivers: findings from a survey of Arkansas families","volume":"18","author":"Grosse","year":"2009","journal-title":"J Child Fam Stud"},{"issue":"2","key":"10.1016\/j.amepre.2015.10.012_bib35","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jpeds.2014.09.039","article-title":"The National Spina Bifida Patient Registry: profile of a large cohort of participants from the first 10 clinics","volume":"166","author":"Sawin","year":"2015","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.amepre.2015.10.012_bib36","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1017\/S1368980012004582","article-title":"Modelling fortification of corn masa flour with folic acid and the potential impact on Mexican-American women with lower acculturation","volume":"16","author":"Hamner","year":"2013","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.amepre.2015.10.012_bib37","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/nyas.12299","article-title":"Processing maize flour and corn meal food products","volume":"1312","author":"Gwirtz","year":"2014","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.amepre.2015.10.012_bib38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/nyas.12325","article-title":"Fortification of corn masa flour with folic acid in the United States: an overview of the evidence","volume":"1312","author":"Hamner","year":"2014","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"10.1016\/j.amepre.2015.10.012_bib39","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/bdra.23158","article-title":"Estimate of the potential impact of folic acid fortification of corn masa flour on the prevention of neural tube defects","volume":"97","author":"Tinker","year":"2013","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"20","key":"10.1016\/j.amepre.2015.10.012_bib40","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199911113412001","article-title":"for the China-U.S. Collaborative Project for Neural Tube Defect Prevention. Prevention of neural-tube defects with folic acid in China","volume":"341","author":"Berry","year":"1999","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.amepre.2015.10.012_bib41","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa067103","article-title":"Reduction in neural-tube defects after folic acid fortification in Canada","volume":"357","author":"De Wals","year":"2007","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.amepre.2015.10.012_bib42","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1002\/ajmg.a.33479","article-title":"Folic acid flour fortification: impact on the frequencies of 52 congenital anomaly types in three South American countries","volume":"152A","author":"Lopez-Camelo","year":"2010","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.amepre.2015.10.012_bib43","series-title":"Folate in Health and Disease","first-page":"179","article-title":"Folic acid fortification: neural tube defect risk reduction\u2014a global perspective","author":"Berry","year":"2010"},{"issue":"3","key":"10.1016\/j.amepre.2015.10.012_bib44","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/nu3030370","article-title":"Folic acid food fortification\u2013its history, effect, concerns, and future directions","volume":"3","author":"Crider","year":"2011","journal-title":"Nutrients"},{"issue":"2-3","key":"10.1016\/j.amepre.2015.10.012_bib45","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.healthpol.2007.01.011","article-title":"Cost-effectiveness of a folic acid fortification program in Chile","volume":"83","author":"Llanos","year":"2007","journal-title":"Health Policy"},{"issue":"4","key":"10.1016\/j.amepre.2015.10.012_bib46","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/bdra.20442","article-title":"Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa","volume":"82","author":"Sayed","year":"2008","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"9","key":"10.1016\/j.amepre.2015.10.012_bib47","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/bdra.23400","article-title":"Preventable spina bifida and anencephaly in Europe","volume":"103","author":"Obeid","year":"2015","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"9","key":"10.1016\/j.amepre.2015.10.012_bib48","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/bdra.10110","article-title":"Random error and undercounting in birth defects surveillance data: implications for inference","volume":"67","author":"Correa-Villasenor","year":"2003","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"61","key":"10.1016\/j.amepre.2015.10.012_bib49","first-page":"1","article-title":"Dietary supplement use among U.S. adults has increased since NHANES III (1988-1994)","author":"Gahche","year":"2011","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.amepre.2015.10.012_bib50","unstructured":"National Birth Defects Prevention Network. Neural Tube Defect Ascertainment Project. 2010. www.nbdpn.org\/current\/2010pdf\/NTD%20fact%20sheet%2001-10%20for%20website.pdf. Accessed September 16, 2015."},{"issue":"4","key":"10.1016\/j.amepre.2015.10.012_bib51","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1017\/S1368980008002565","article-title":"A cost-effectiveness analysis of folic acid fortification policy in the United States","volume":"12","author":"Bentley","year":"2009","journal-title":"Public Health Nutr"},{"issue":"5","key":"10.1016\/j.amepre.2015.10.012_bib52","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2257.2004.00631.x","article-title":"The relationship between serum cobalamin concentration and mean red cell volume at varying concentrations of serum folate","volume":"26","author":"Metz","year":"2004","journal-title":"Clin Lab Haematol"},{"issue":"4","key":"10.1016\/j.amepre.2015.10.012_bib53","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/ajcn\/86.4.1187","article-title":"Proportion of individuals with low serum vitamin B-12 concentrations without macrocytosis is higher in the post folic acid fortification period than in the pre folic acid fortification period","volume":"86","author":"Wyckoff","year":"2007","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.amepre.2015.10.012_bib54","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3945\/jn.113.183095","article-title":"The prevalence of low serum vitamin B-12 status in the absence of anemia or macrocytosis did not increase among older U.S. adults after mandatory folic acid fortification","volume":"144","author":"Qi","year":"2014","journal-title":"J Nutr"},{"issue":"1","key":"10.1016\/j.amepre.2015.10.012_bib55","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2011-000653","article-title":"Cancer risk with folic acid supplements: a systematic review and meta-analysis","volume":"2","author":"Wien","year":"2012","journal-title":"BMJ Open"},{"issue":"9871","key":"10.1016\/j.amepre.2015.10.012_bib56","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0140-6736(12)62001-7","article-title":"Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals","volume":"381","author":"Vollset","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.amepre.2015.10.012_bib57","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/0091270010365553","article-title":"Pediatric cancer rates after universal folic acid flour fortification in Ontario","volume":"51","author":"Grupp","year":"2011","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.amepre.2015.10.012_bib58","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1542\/peds.2011-3418","article-title":"Childhood cancer incidence trends in association with U.S. folic acid fortification (1986-2008)","volume":"129","author":"Linabery","year":"2012","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.amepre.2015.10.012_bib59","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/bdra.20210","article-title":"Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population-based study","volume":"73","author":"Canfield","year":"2005","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"6 Pt 2","key":"10.1016\/j.amepre.2015.10.012_bib60","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1301\/nr.2004.jun.S35-S39","article-title":"Folic acid food fortification in Canada","volume":"62","author":"Ray","year":"2004","journal-title":"Nutr Rev"},{"issue":"10","key":"10.1016\/j.amepre.2015.10.012_bib61","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1161\/CIRCULATIONAHA.105.570846","article-title":"Improvement in stroke mortality in Canada and the United States, 1990 to 2002","volume":"113","author":"Yang","year":"2006","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.amepre.2015.10.012_bib62","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1742-1241.2012.02929.x","article-title":"Efficacy of folic acid supplementation in stroke prevention: new insight from a meta-analysis","volume":"66","author":"Huo","year":"2012","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.amepre.2015.10.012_bib63","first-page":"1","article-title":"The effect of folate fortification on folic acid-based homocysteine-lowering intervention and stroke risk: a meta-analysis","author":"Zeng","year":"2014","journal-title":"Public Health Nutr"},{"issue":"13","key":"10.1016\/j.amepre.2015.10.012_bib64","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/jama.2015.2274","article-title":"Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: The CSPPT Randomized Clinical Trial","volume":"313","author":"Huo","year":"2015","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.amepre.2015.10.012_bib65","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/jnci\/djn434","article-title":"How should we value lives lost to cancer?","volume":"100","author":"Ramsey","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.amepre.2015.10.012_bib66","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/hec.1375","article-title":"The valuation of prenatal life in economic evaluations of perinatal interventions","volume":"18","author":"Simon","year":"2009","journal-title":"Health Econ"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379715006893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379715006893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T03:58:27Z","timestamp":1537070307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379715006893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":66,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0749379715006893"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2015.10.012","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retrospective Assessment of Cost Savings From Prevention","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2015.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}